Ribosome inactivating proteins (RIPs) : a promising candidate for industrial biotechnology
Puri, Munish, Kaur, Inderdeep and Batra, J. K. 2009, Ribosome inactivating proteins (RIPs) : a promising candidate for industrial biotechnology, in Proceedings of the 2009 Bangalore Bio conference, The Conference, [Bangalore, India], pp. 71-71.
Attached Files
(Some files may be inaccessible until you login with your Deakin Research Online credentials)
Name
Description
MIMEType
Size
Downloads
Title
Ribosome inactivating proteins (RIPs) : a promising candidate for industrial biotechnology
The ribosome inactivating proteins (RIPs) from plants possess RNA N- glycosidase activity that depurinates the major rRNA, thus damaging ribosomes in an irreversible manner and arresting protein synthesis. RIPs are presently classified as rRNA N-glycosidase in the enzyme nomenclature (EC 3.2.2.22) and do exhibit other enzymatic activities such as ribonuclease and deoxyribonuclease activities. RIPs have been shown to manifest anti-tumor, anti-viral and anti-microbial activities. RIPs are detected in some medicinal plants but the yields are insufficient to warrant their availability to conduct clinical trials thus limiting its therapeutic potential. Here, an approach based on "bioprocess development" shall be discussed that may enhance the yield of RIPs. It is anticipated; with the involvement of “Industrial biotechnology” the eventual availability of RIPs in large quantities shall be accomplished.
Language
eng
Field of Research
100302 Bioprocessing, Bioproduction and Bioproducts
Socio Economic Objective
860802 Human Diagnostics
HERDC Research category
E2.1 Full written paper - non-refereed / Abstract reviewed